Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05670028Phase 2Not yet recruiting
Phase 2, randomised, open-label trial (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Early neurological recovery at 7 days. Planned start Jun 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05670028.